Impact of diet on irinotecan toxicity in mice
-
Add time:07/21/2019 Source:sciencedirect.com
Irinotecan is highly effective in the treatment of metastatic colorectal cancer as well as many other cancers. However, irinotecan is known to cause severe diarrhea, which pose significant problems in patients undergoing irinotecan based chemotherapy. Dietary and herbal components have shown promise in improving gastrointestinal health. Therefore, we compared the effect of grain-based chow diet containing phytoestrogens and corn/alfalfa as fat source to purified diets containing either animal-derived fat source (lard) or plant-derived fat source (soybean oil) on irinotecan-induced toxicities in mice. The concentration of the toxic metabolite, SN-38, was measured in the serum, and the activity of main enzyme, carboxylesterase (CEs) involved in biotransformation of irinotecan to SN-38 formation was measured in the liver. We found that the grain-based diet was protective against irinotecan-induced diarrhea. Interestingly, purified diet containing lard caused fatty liver in mice, while grain-based chow diet containing corn/alfa-alfa or purified diet with soybean oil did not cause fat deposition in the liver. Serum SN-38 concentration was significantly higher in the mice fed with purified diets compared to the chow-fed mice. Hepatic CEs activity was induced in the presence of irinotecan in mice on purified diets, but not chow diet. These results indicate that components of grain-based natural diet (presumably phytoestrogens and/or the macronutrients balance) compared to purified diets may have a beneficial effect by controlling the adverse effects of irinotecan in cancer patients.
We also recommend Trading Suppliers and Manufacturers of Irinotecan hydrochloride (cas 100286-90-6). Pls Click Website Link as below: cas 100286-90-6 suppliers
Prev:Active loading liposomal Irinotecan hydrochloride (cas 100286-90-6): Preparation, in vitro and in vivo evaluation
Next:Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Role of Glucocorticoid Receptor in the Regulation of Cellular Sensitivity to Irinotecan hydrochloride (cas 100286-90-6)07/26/2019
- Salvage chemotherapy with a combination of Irinotecan hydrochloride (cas 100286-90-6) and mitomycin C in elderly Japanese patients with gynecological malignancies: a pilot study07/25/2019
- Halloysite nanotubes as carriers for irinotecan: Synthesis and characterization by experimental and molecular simulation methods07/24/2019
- Voltammetric behaviour of the anticancer drug irinotecan and its metabolites in acetonitrile. Implications for electrochemical therapeutic drug monitoring07/23/2019
- Clinical effects of Irinotecan hydrochloride (cas 100286-90-6) in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer07/22/2019
- Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats07/20/2019
- Active loading liposomal Irinotecan hydrochloride (cas 100286-90-6): Preparation, in vitro and in vivo evaluation07/19/2019
- Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride (cas 100286-90-6) in rat plasma by using high performance liquid chromatography-diode array detector07/18/2019
- A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of Irinotecan hydrochloride (cas 100286-90-6) liposome injection07/17/2019
-
Health and Chemical more >


